We are committed to leading the way in adopting and applying the highest standards of good governance, ethics and transparency in our industry.
Collaborative work between healthcare professionals and commercial life sciences organizations has long been a positive driver for advancements in patient care and progression of innovative medicine.
Shire’s goal is to reinforce the authentic relationship between pharmaceutical companies and healthcare professionals, by supporting the principles of transparency and disclosing our annual payments as directed by the EFPIA and local disclosure codes.To view our EFPIA reports please click here.
Patient Groups – or patient advocacy groups and patient organizations – are important partners for Shire. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community.
We support patient organizations in our therapeutic areas through sponsorships, grants and donations.
Shire provides funding in the form of unrestricted educational grants to support independent medical education activities for healthcare professionals.
Shire makes charitable donations (to include both cash and in-kind giving) to local, national and international organizations that support Shire’s communities and/or diseases in its therapeutic focus area.
Below are several disclosure reports of funding provided by Shire.
Given differences in the timing between CMS’ Open Payments public disclosure and the Transparency reports posted by Shire, there may be slight differences between the two reports. Any inquiries should be directed to firstname.lastname@example.org.